Looks like the final patient will be enrolled in April '23 and only 12 weeks to report on results. This is a quick trial. Another advantage of having a solution that has very few moving parts and yet produces such rapid results, along with the body's input obviously.
Ann: First Patient enrolled - SynPath Diabetic Foot Ulcer Trial, page-19
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.59 |
Change
0.000(0.00%) |
Mkt cap ! $1.787B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8459 | $2.77 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.47 | 56198 | 9 |
View Market Depth
| Last trade - 09.57am 18/07/2024 (20 minute delay) ? |
| PNV (ASX) Chart |
Day chart unavailable